ロード中...
Long-Term Efficacy of Adalimumab in Patients With Intestinal Behcet’s Disease: Eight Consecutive Cases
The long-term efficacy and safety of adalimumab (ADA) for the treatment of intestinal Behcet’s disease (BD) in the clinical setting have not been evaluated previously. This retrospective study evaluated the 52-week efficacy of ADA in BD patients. A total of eight patients who were refractory to conv...
保存先:
| 出版年: | J Clin Med Res |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elmer Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4780498/ https://ncbi.nlm.nih.gov/pubmed/26985255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2477w |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|